A Phase 1 Study of Venetoclax in combination with Inotuzumab Ozogamicin for B-cell Acute lymphoblastic leukemia (B-ALL)
ENROLLING
Trial ID:
NCT05016947 Protocol # :
21-196
Phase
I
Disease Sites
Lymphoid Leukemia
Principal Investigator
Luskin, Marlise, R.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-196
21-196